» Authors » Juan J Gavira

Juan J Gavira

Explore the profile of Juan J Gavira including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 322
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Montero-Calle P, Flandes-Iparraguirre M, Kuebler B, Aran B, Larequi E, Anaut I, et al.
Stem Cell Res . 2023 Sep; 71:103189. PMID: 37660554
Transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is a life-threatening disease caused by the abnormal production of misfolded TTR protein by liver cells, which is then released systemically. Its amyloid deposition in...
2.
Muniz-Saenz-Diez J, Ezponda A, Caballeros M, de la Fuente A, Gavira J, Bastarrika G
Int J Cardiovasc Imaging . 2023 Jun; 39(9):1765-1774. PMID: 37354385
Owing to its pharmacodynamics and posology, the use of regadenoson for stress cardiac magnetic resonance (CMR) has potential advantages over other vasodilators. We sought to evaluate the safety, hemodynamic response...
3.
Montero-Calle P, Flandes-Iparraguirre M, Mountris K, S de la Nava A, Laita N, Rosales R, et al.
Biofabrication . 2022 Aug; 14(4). PMID: 36007502
Biofabrication of human tissues has seen a meteoric growth triggered by recent technical advancements such as human induced pluripotent stem cells (hiPSCs) and additive manufacturing. However, generation of cardiac tissue...
4.
Garcia-Baizan A, Caballeros M, Ezponda A, Manrique R, Gavira J, Rabago G, et al.
AJR Am J Roentgenol . 2021 Feb; 216(5):1216-1221. PMID: 33624522
This study aimed to evaluate the long-term prognostic value of coronary CTA (CCTA) in heart transplant recipients. The records of 114 patients who had undergone a heart transplant (mean age,...
5.
Garcia-Baizan A, Millor M, Bartolome P, Ezponda A, Pueyo J, Gavira J, et al.
Int J Cardiovasc Imaging . 2018 Nov; 35(4):675-682. PMID: 30426300
To evaluate the vasodilator effect of adenosine triphosphate (ATP) compared with adenosine in stress perfusion cardiac magnetic resonance (CMR) examinations. A total of thirty-three patients underwent clinically indicated stress/rest perfusion...
6.
Moreno M, Eiros R, Gavira J, Gallego C, Gonzalez A, Ravassa S, et al.
Med Clin North Am . 2016 Nov; 101(1):43-52. PMID: 27884234
The chronic hemodynamic load imposed by hypertension on the left ventricle leads to lesions in the myocardium that result in structural remodeling, which provides support for alterations in cardiac function,...
7.
Calvo N, Salterain N, Arguedas H, Macias A, Esteban A, Garcia de Yebenes M, et al.
Europace . 2015 May; 17(10):1533-40. PMID: 25935163
Aims: Left atrial appendage (LAA) is the source of thrombi in up to 90% of patients with non-valvular atrial fibrillation (AF). Catheter ablation (CA) is an effective treatment for symptomatic...
8.
Calvo N, Arguedas H, Lopez G, Diaz C, Gavira J, Garcia-Bolao I
Rev Esp Cardiol (Engl Ed) . 2014 Apr; 66(10):827-9. PMID: 24773869
No abstract available.
9.
Formiga F, Pelacho B, Garbayo E, Imbuluzqueta I, Diaz-Herraez P, Abizanda G, et al.
J Control Release . 2013 Nov; 173:132-9. PMID: 24200746
Acidic fibroblast growth factor (FGF1) and neuregulin-1 (NRG1) are growth factors involved in cardiac development and regeneration. Microparticles (MPs) mediate cytokine sustained release, and can be utilized to overcome issues...
10.
Arana M, Gavira J, Pena E, Gonzalez A, Abizanda G, Cilla M, et al.
Biomaterials . 2013 Oct; 35(1):143-51. PMID: 24119456
Although transplantation of adipose-derived stem cells (ADSC) in chronic myocardial infarction (MI) models is associated with functional improvement, its therapeutic value is limited due to poor long-term cell engraftment and...